NewCardio names new vice president and CMO

NewCardio, a cardiac diagnostic and services company, has appointed Ihor Gussak as its new chief medical officer and vice president, effective immediately.

Dr Gussak joins NewCardio from Boehringer Ingelheim Pharmaceuticals, where he held a senior executive role for the past year.

Dr Gussak received his MD from Tartu University School of Medicine (Tartu, Estonia), and his PhD in medical sciences/cardiac electrophysiology (acute myocardial ischemia in clinic and experiments) from the National Center for Surgical Treatment of Severe Cardiac Rhythm Disturbance and Cardiac Pacing (Kaunas, Lithuania).

Branislav Vajdic, president and CEO of NewCardio, said : "Dr Gussak is a recognized leader around the world in the area of clinical trials and cardiac safety. We are exceptionally pleased to add him as a senior member of our management team and look forward to benefiting from his expertise and leadership."